Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

Clinical trial NCT00709202 · COMPLETED

Trial details

NCT number: NCT00709202
Sponsor: Nathan Kline Institute for Psychiatric Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Schizophreniform Disorder Bipolar I Disorder Bipolar II Bipolar NOS(Not Otherwise Specified)Psychotic Disorder Not Otherwise Specified Autism Spectrum Disorder

Start date: 2008-07-01
Primary completion: 2016-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.